Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997

American Journal of Public Health

Volumn 90, Issue 2, 2000, Pages 223-229

  Feikin, Daniel R ^b,l   Schuchat, Anne ^b   Kolczak, Margarette ^a   Barrett, Nancy L ^c   Harrison, Lee H ^d   Lefkowitz, Lewis ^e   McGeer, Allison ^f   Farley, Monica M ^g   Vugia, Duc J ^h   Lexau, Catherine ⁱ   Stefonek, Karen R ^j   Patterson, Jan E ^k   Jorgensen, James H ^k  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c CDC   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^f UNIVERSITY OF TORONTO   (Canada)

^g EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

ⁱ MINNESOTA DEPARTMENT OF HEALTH   (United States)

^j Oregon State Health Division   (United States)

^k UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^l Centers for Dis Contr and Prev ^*  (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; PENICILLIN DERIVATIVE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CHILD; FEMALE; HOSPITALIZATION; HUMAN; LOBAR PNEUMONIA; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; RISK FACTOR; STREPTOCOCCUS PNEUMONIAE;

EID: 0033959389     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.90.2.223     Document Type: Article

References (50)

1. Osler W. The Principles and Practice of Medicine. New York, NY: Appleton; 1901:108.
2. Mufson MA. Pneumococcal infections. JAMA. 1981;246:1942-1948.
3. Fedson DS, Musher DM. Pneumococcal vaccine. In: Plotkin SA, Mortimer EA, eds. Vaccines. Philadelphia, Pa: WB Saunders Co; 1994:517-563.
4. Marston BJ, Plouffe JF, File TM Jr, et al. Incidence of community-acquired pneumonia requiring hospitalization: results of a population-based active surveillance study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch Intern Med. 1997;157: 1709-1718.
5. Fine MJ, Smith MA, Carson CA, et al. Prognosis and outcomes of patients with community-acquired pneumonia: a meta-analysis. JAMA. 1996;275:134-141.
6. Austrian R, Gold J. Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia. Ann Intern Med. 1964;60: 759-776.
7. Hook EW III, Horton CA, Schaberg DR. Failure of intensive care unit support to influence mortality from pneumococcal bacteremia. JAMA. 1983;249:1055-1057.
8. Kramer MR, Rudensky B, Hadas-Halperin I, Isacsohn M, Melzer E. Pneumococcal bacteremia - no change in mortality in 30 years: analysis of 104 cases and review of the literature. Isr J Med Sci. 1987;23:174-180.
9. Ortqvist A, Grepe A, Julander I, Kalin M. Bacteremic pneumococcal pneumonia in Sweden: clinical course and outcome and comparison with non-bacteremic pneumococcal and mycoplasmal pneumonias. Scand J Infect Dis. 1988;20:163-171.
10. Afessa B, Greaves WL, Frederick WR. Pneumococcal bacteremia in adults: a 14-year experience in an inner-city university hospital. Clin Infect Dis. 1995;21:345-351.
11. Marrie TJ. Bacteraemic pneumococcal pneumonia: a continuously evolving disease. J Infect. 1992;24:247-255.
12. Bruyn GA, van der Meer JW, Hermans J, Knoppert W. Pneumococcal bacteremia in adults over a 10-year period at University Hospital, Leiden. Rev Infect Dis. 1988;10:446-450.
13. Duchin JS, Breiman RF, Diamond A, et al. High prevalence of multidrug-resistant Streptococcus pneumoniae among children in a rural Kentucky community. Pediatr Infect Dis J. 1995;14: 745-750.
14. Arnold KE, Leggiadro RJ, Breiman RF, et al. Risk factors for carriage of drug-resistant Streptococcus pneumoniae among children in Memphis, Tennessee. J Pediatr. 1996;128:757-764.
15. Catalan MJ, Fernandez JM, Vazquez A, Varela de Seijas E, Suarez A, Bernaldo de Quiros JC. Failure of cefotaxime in the treatment of meningitis due to relatively resistant Streptococcus pneumoniae. Clin Infect Dis. 1994;18:766-769.
16. Sloas MM, Barrett FF, Chesney PJ, et al. Cephalosporin treatment failure in penicillin-and cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr Infect Dis J. 1992;11:662-666.
17. Therapy for children with invasive pneumococcal infections: American Academy of Pediatrics Committee on Infectious Diseases. Pediatrics. 1997;99:289-299.
18. International Classification of Diseases, 9th Revision. Geneva, Switzerland: World Health Organization; 1980.
19. Schuchat A, Robinson K, Wenger JD, et al. Bacterial meningitis in the United States in 1995: Active Surveillance Team. N Engl J Med. 1997;337:970-976.
20. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Tests (M100-58). Vol 18. Villanova, Pa: National Committee for Clinical Laboratory Standards; 1998. Approved Standard. M7-A4.
21. Armitrage P, Berry G. Statistical Methods in Medical Research. Oxford, England: Blackwell Scientific Publications; 1994:438.
22. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 1997;46:1-24.
23. Janoff EN, Breiman RF, Daley CL, Hopewell PC. Pneumococcal disease during HIV infection: epidemiologic, clinical, and immunologic perspectives. Ann Intern Med. 1992;117: 314-324.
24. Redd SC, Rutherford GW III, Sande MA, et al. The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents. J Infect Dis. 1990;162: 1012-1017.
25. Tilghman RC, Finland M. Clinical significance of bacteremia in pneumococcic pneumonia. Arch Intern Med. 1937;59:602-619.
26. Wennberg JE, Freeman JL, Shelton RM, Bubolz TA. Hospital use and mortality among Medicare beneficiaries in Boston and New Haven. N Engl J Med. 1989;321:1168-1173.
27. Hofmann J, Cetron MS, Farley MM, et al. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med. 1995;333: 481-486.
28. Shriver MD. Ethnic variation as a key to the biology of human disease. Ann Intern Med. 1997;127:401-403.
29. Pallares R, Gudiol F, Linares J, et al. Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. N Engl J Med. 1987;317:18-22.
30. Feldman C, Kallenbach JM, Miller SD, Thorburn JR, Koornhof HJ. Community-acquired pneumonia due to penicillin-resistant pneumococci. N Engl J Med. 1985;313:615-617.
31. Buckingham SC, Brown SP, San Joaquin VH. Breakthrough bacteremia and meningitis during treatment with cephalosporins parenterally for pneumococcal pneumonia. J Pediatr. 1998;132: 174-176.
32. Pallares R, Linares J, Vadillo M, et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain [published erratum appears in N Engl J Med. 1995;333:1655]. N Engl J Med. 1995;333:474-480.
33. Friedland IR. Comparison of the response to antimicrobial therapy of penicillin-resistant and penicillin-susceptible pneumococcal disease. Pediatr Infect Dis J. 1995;14:885-890.
34. Craig WA, Andes D. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatr Infect Dis J. 1996;15:255-259.
35. Barry B, Muffat-Joly M, Gehanno P, Pocidalo JJ. Effect of increased dosages of amoxicillin in treatment of experimental middle ear otitis due to penicillin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother. 1993;37: 1599-1603.
36. Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis. 1998;26: 1-10.
37. Klugman KP, Friedland IR, Bradley JS. Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis. Antimicrob Agents Chemother. 1995;39: 1988-1992.
38. Dagan R, Abramson O, Leibovitz E, et al. Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin. Pediatr Infect Dis J. 1996;15:980-985.
39. Gehanno P, Lenoir G, Berche P. In vivo correlates for Streptococcus pneumoniae penicillin resistance in acute otitis media. Antimicrob Agents Chemother. 1995;39:271-272.
40. Tateda K, Takashima K, Miyazaki H, et al. Noncompromised penicillin-resistant pneumococcal pneumonia CBA/J mouse model and comparative efficacies of antibiotics in this model. Antimicrob Agents Chemother. 1996;40: 1520-1525.
41. Friedland IR, McCracken GH Jr. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N Engl J Med. 1994;331:377-382.
42. Breiman RF, Butler JC, Tenover FC, Elliot JA, Facklam RR. Emergence of drug-resistant pneumococcal infections in the United States. JAMA. 1994;271:1831-1835.
43. Bartlett JG, Breiman RF, Mandell LA, File TM Jr. Community-acquired pneumonia in adults: guidelines for management. Clin Infect Dis. 1998;26:811-838.
44. Visalli MA, Jacobs MR, Appelbaum PC. Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin, and clindamycin. Antimicrob Agents Chemother. 1997; 41:1867-1870.
45. Barry AL, Fuchs PC, Brown SD. Macrolide resistance among Streptococcus pneumoniae and Streptococcus pyogenes isolates from out-patients in the USA. J Antimicrob Chemother. 1997;40:139-140.
46. Linares J, Alonso T, Perez JL, et al. Decreased susceptibility of penicillin-resistant pneumococci to twenty-four beta-lactam antibiotics. J Antimicrob Chemother. 1992;30:279-288.
47. Williams WW, Hickson MA, Kane MA, Kendal AP, Spika JS, Hinman AR. Immunization policies and vaccine coverage among adults: the risk for missed opportunities [published erratum appears in Ann Intern Med. 1988;109:348]. Ann Intern Med. 1988;108:616-625.
48. Pneumococcal polysaccharide vaccine. MMWR Morb Mortal Wkly Rep. 1989;38:64-68.
49. Influenza and pneumococcal vaccination levels among adults aged greater than or equal to 65 years - United States. MMWR Morb Mortal Wkly Rep. 1998;47(38):797-802.
50. National Center for Health Statistics. Vital Statistics of the United States, 1990, Vol II, Mortality, Part A. Washington, DC: Public Health Service; 1994:374. DHHS publication (PHS) 95-1101.